U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX18945607: GSM6918983: RNA-seq, Early set, 1 dpi, rep 4; Mus musculus; RNA-Seq
1 ILLUMINA (Illumina NovaSeq 6000) run: 44.5M spots, 9G bases, 2.6Gb downloads

External Id: GSM6918983_r1
Submitted by: Hyeshik Chang Lab, School of Biological Sciences, Seoul National University
Study: Heterogeneous ribonucleoprotein interactions and impeded translational elongation in the respiratory tissue of SARS-CoV-2 pathology (RNA-Seq)
show Abstracthide Abstract
Translational regulation in in vivo tissue environments during viral pathogenesis has hardly been scrutinized due to the lack of tissue translatomes upon viral infection despite a number of the translatome studies on virus-infected cells cultured in vitro. We constructed the first temporal profile of lung translatomes during SARS-CoV-2 pathogenesis by applying ribosome profiling (Ribo-seq) to a severe COVID-19 mouse model. Unexpectedly, we observed gradual accumulations of non-canonical Ribo-seq reads representing hitherto-unidentified ribonucleoproteins (RNPs) that are likely involved in impeded translational elongation in the infected tissues. Contemporarily developing ribosome heterogeneity with prominently deviated 5S rRNP association supported the malfunction of elongating ribosomes. The analyses of canonical Riboseq reads (ribosome footprints) highlighted two obstructive characteristics to host gene expression: attenuated translation for transcriptionally up-regulated genes including immune response genes and ribosome stalling on codons within transmembrane domain-coding regions. Our study elucidates hidden molecular features of gene regulation in vivo underlying SARS-CoV-2 pathogenesis. Overall design: RNA-seq for lung tissues of K18-hACE2 transgenic mice infected by SARS-CoV-2. For the library construction, we divided conditions as two groups, the early set (Control for the early set, 1 day post-infection, 2 days post-infection) and late set (Control for the late set, 5 days post-infection, 7 days post-infection). For each condition, we prepared quadruplets.
Sample: RNA-seq, Early set, 1 dpi, rep 4
SAMN32603045 • SRS16369616 • All experiments • All runs
Organism: Mus musculus
Library:
Name: GSM6918983
Instrument: Illumina NovaSeq 6000
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: PAIRED
Construction protocol: Quick-freeze-applied lung tissue samples were homogenized within the lysis buffer (10 mM/mL Tris-HCl pH 7.4 (AM9850G, AM9855G Invitrogen), 5 mM/mL MgCl2 (#AM9530G Ambion), 100 mM/mL KCl (#AM9640G Ambion), 2 mM/mL dithiothreitol (DTT, #707265ML ThermoFisher), 300 μg/mL cycloheximide (CHX, #C1988-1G Sigma-Aldrich), 1% Triton X-100 (#T8787 Sigma-Aldrich), 1X protease inhibitor (#P3100-001 GenDEPOT), 2 μL/mL SUPERase inhibitor (#AM2696, Invitrogen) and 2 μL/mL RNase inhibitor (#AM2694 Invitrogen)) for five minutes on ice followed by incubation at 4°C for 30 minutes with the additional lysis buffer which contained 3 times less amount of CHX. After incubation, samples were spun down and the supernatant was divided into two parts each for RNA-seq and Ribo-seq. The half for RNA-seq was treated with TRIzol LS (#10296028 Invitrogen). After the purification of RNA from TRIzol-treated samples, libraries were constructed with TruSeq Stranded Total RNA Library Prep Gold (#20020599 Illumina) as per the manufacturer's protocol, and then sequenced by the NovaSeq 6000 system.
Runs: 1 run, 44.5M spots, 9G bases, 2.6Gb
Run# of Spots# of BasesSizePublished
SRR2298951044,536,2779G2.6Gb2023-12-01

ID:
26077120

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...